CALHM1 and Alzheimer disease: A recent study demonstrated that CALHM1 deficiency in mice leads to cognitive and neuronal deficits, which manifest memory impairment and hippocampal long-term potentiation (LTP) [40], pointing to CALHM1 as a potential treatment target in AD.